If you feel that you have been making less use of cash lately, you are not the only one. 2016 may finally be the year that cash loses its title as king, forfeiting that top position to credit and debit cards instead. Based on research recently conducted by Euromonitor International, a market research company, consumers around the globe are expected to spend nearly $23.1 trillion on goods and services through alternative means, eclipsing the $22.6 trillion forecast for cash transactions.
The traditional certificate of deposit, otherwise known as the CD, has long been a popular instrument for savers to consider. Simply put, these products generally offer higher interest rates when compared to traditional savings accounts in exchange for a commitment of those funds by savers for a predetermined period of time. That said, Wall Street had taken to morph this basic CD into something that can yield, ahem, far different results. Why, then, has there been an uptick in interest over the last several years? Simple: investors have been starved for yield amid a record low interest rate environment!
With drug prices under heightened scrutiny from the public as well as policymakers due to the recent controversy surrounding the EpiPen price hike, there was some surprising and reassuring news from Allergan, a pharmaceutical firm, today.